2922 related articles for article (PubMed ID: 7688498)
41. Myelodysplastic syndrome following treatment of malignant melanoma with vincristine, ACNU, and dacarbazine.
Kageshita T; Kuribayashi N; Ono T
J Dermatol; 2000 Mar; 27(3):178-80. PubMed ID: 10774145
[TBL] [Abstract][Full Text] [Related]
42. [A combination chemotherapy of ACNU and DTIC for advanced malignant melanoma].
Domyo M; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Inoue K; Aiba K; Nagata T; Miyamoto H
Gan To Kagaku Ryoho; 1982 May; 9(5):874-9. PubMed ID: 6964041
[TBL] [Abstract][Full Text] [Related]
43. The use of DAV (DTIC, ACNU and VCR) and natural interferon-beta combination therapy in malignant melanoma.
Nagatani T; Ichiyama S; Onuma R; Miyazawa M; Matsuzaki T; Miyagawa K; Baba N; Uchiyama M; Nakajima H
Acta Derm Venereol; 1995 Nov; 75(6):494. PubMed ID: 8651034
[No Abstract] [Full Text] [Related]
44. [Combination of dacarbazine, cisplatin and interferon alpha in the treatment of metastatic melanoma].
Tessier MH; Mansat E; Legoux B; Litoux P; Dreno B
Ann Dermatol Venereol; 1996; 123(9):538-42. PubMed ID: 9615103
[TBL] [Abstract][Full Text] [Related]
45. Treatment of advanced malignant melanoma with vinblastine, bleomycin, and cisplatin.
Bajetta E; Rovej R; Buzzoni R; Vaglini M; Bonadonna G
Cancer Treat Rep; 1982 Jun; 66(6):1299-302. PubMed ID: 6177408
[TBL] [Abstract][Full Text] [Related]
46. [A case of malignant melanoma responded to chemotherapy including DTIC and local injection of OK-432].
Tsuji H; Sawada S; Okano R; Shimazaki C; Nakanishi S; Haruyama H; Isemura T; Nakagawa M; Ijichi H; Ueda K
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1851-5. PubMed ID: 6964031
[TBL] [Abstract][Full Text] [Related]
47. [An autopsy case of neurocutaneous melanosis associated with intracerebral malignant melanoma].
Sawamura Y; Abe H; Murai H; Tashiro K; Doi S
No To Shinkei; 1987 Aug; 39(8):789-95. PubMed ID: 3322333
[TBL] [Abstract][Full Text] [Related]
48. Dacarbazine, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma: a phase II study.
Gundersen S
Cancer Treat Rep; 1987 Nov; 71(11):997-9. PubMed ID: 3677119
[No Abstract] [Full Text] [Related]
49. Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group.
Daponte A; Ascierto PA; Gravina A; Melucci MT; Palmieri G; Comella P; Cellerino R; DeLena M; Marini G; Comella G;
Cancer; 2000 Dec; 89(12):2630-6. PubMed ID: 11135225
[TBL] [Abstract][Full Text] [Related]
50. [Malignant melanoma in Japan: unique distribution and effect of DAV chemoimmunotherapy (part II)].
Ishihara K; Hayasaka K; Ikeda S; Terakado T; Kukita A; Seki Y; Jimbow K; Suzuki M
Gan To Kagaku Ryoho; 1984 Mar; 11(3):467-73. PubMed ID: 6703721
[TBL] [Abstract][Full Text] [Related]
51. [A case report of anorectal malignant melanoma showing a complete response after DTIC/ACNU/VCR therapy].
Sasaki S; Kojima T; Hidemura A; Hatanaka K; Uekusa T; Ishimaru M
Gan To Kagaku Ryoho; 2010 Oct; 37(10):1999-2002. PubMed ID: 20948273
[TBL] [Abstract][Full Text] [Related]
52. Biochemotherapy in patients with advanced head and neck mucosal melanoma.
Bartell HL; Bedikian AY; Papadopoulos NE; Dett TK; Ballo MT; Myers JN; Hwu P; Kim KB
Head Neck; 2008 Dec; 30(12):1592-8. PubMed ID: 18798304
[TBL] [Abstract][Full Text] [Related]
53. Lomustine, vincristine, and procarbazine in the treatment of metastatic malignant melanoma.
Shelley W; Quirt I; Bodurtha A; Iscoe N; Russell J; Paterson A; Young V
Cancer Treat Rep; 1985 Sep; 69(9):941-4. PubMed ID: 2992784
[TBL] [Abstract][Full Text] [Related]
54. [Skin cancer melanoma].
Ishihara K
Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():173-84. PubMed ID: 10410672
[TBL] [Abstract][Full Text] [Related]
55. [Malignant melanoma in Japan: unique distribution and effect of DAV chemoimmunotherapy].
Jimbow K; Takahashi H; Ishihara K; Hayasaka K; Kukita A; Seki Y; Ikeda S; Terakado T
Gan To Kagaku Ryoho; 1982 Nov; 9(11):1942-9. PubMed ID: 7184382
[TBL] [Abstract][Full Text] [Related]
56. Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients.
Atzpodien J; Morawek L; Fluck M; Reitz M
Cancer Chemother Pharmacol; 2009 Oct; 64(5):901-5. PubMed ID: 19229537
[TBL] [Abstract][Full Text] [Related]
57. Two cases of malignant melanoma of the toe developed skin ulcers following local injection of natural beta-interferon.
Kurashige Y; Irisawa R; Abe N; Saito M; Tsuboi R
J Dermatol; 2012 Dec; 39(12):1037-8. PubMed ID: 22758215
[No Abstract] [Full Text] [Related]
58. Treatment of metastatic malignant melanoma with dacarbazine and cisplatin.
Oratz R; Speyer JL; Green M; Blum R; Wernz JC; Muggia FM
Cancer Treat Rep; 1987 Sep; 71(9):877-8. PubMed ID: 3621224
[No Abstract] [Full Text] [Related]
59. [Clinical trials of supplementary chemotherapy in cases of malignant melanoma of the skin with unfavorable prognosis after surgical treatment].
Dobrek Z
Wiad Lek; 1987 Feb; 40(4):237-41. PubMed ID: 3617746
[No Abstract] [Full Text] [Related]
60. Complete remission of metastatic clear cell sarcoma with DAV chemotherapy.
Fujimoto M; Hiraga M; Kiyosawa T; Murakami T; Murata S; Ohtsuki M; Nakagawa H
Clin Exp Dermatol; 2003 Jan; 28(1):22-4. PubMed ID: 12558622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
